Evidence map›Paper›PMID 29293892›Full record

ArticleBrain : a journal of neurology2018

Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.

Thomas E Cope, Timothy Rittman, Robin J Borchert, P Simon Jones, Deniz Vatansever, Kieren Allinson, Luca Passamonti, Patricia Vazquez Rodriguez, W Richard Bevan-Jones, John T O'Brien and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 164 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 2 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 2 syntheses or guidelines pooled it, 253 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. The impact of polygenic risk for alzheimer's disease on neurotransmitter-related grey matter atrophy in the alzheimer continuum.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Thomas E CopeDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Timothy RittmanDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Robin J BorchertDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
P Simon JonesDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Deniz VatanseverDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Kieren AllinsonDepartment of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Luca PassamontiDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Patricia Vazquez RodriguezDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
W Richard Bevan-JonesDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
John T O'BrienDepartment of Psychiatry, University of Cambridge, Cambridge, UK.
James B RoweDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
University of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBMedical Research Council · GB

Funding

Medical Research Council G1100464Medical Research Council MC-A060-5PQ30Medical Research Council MC_U105597119Medical Research Council MC_UU_00005/12Medical Research Council MR/M009041/1Medical Research Council MR/M024873/1Wellcome TrustWellcome Trust JBR 103838
6 · The paper itself

Abstract

Alzheimer's disease and progressive supranuclear palsy (PSP) represent neurodegenerative tauopathies with predominantly cortical versus subcortical disease burden. In Alzheimer's disease, neuropathology and atrophy preferentially affect 'hub' brain regions that are densely connected. It was unclear whether hubs are differentially affected by neurodegeneration because they are more likely to receive pathological proteins that propagate trans-neuronally, in a prion-like manner, or whether they are selectively vulnerable due to a lack of local trophic factors, higher metabolic demands, or differential gene expression. We assessed the relationship between tau burden and brain functional connectivity, by combining in vivo PET imaging using the ligand AV-1451, and graph theoretic measures of resting state functional MRI in 17 patients with Alzheimer's disease, 17 patients with PSP, and 12 controls. Strongly connected nodes displayed more tau pathology in Alzheimer's disease, independently of intrinsic connectivity network, validating the predictions of theories of trans-neuronal spread but not supporting a role for metabolic demands or deficient trophic support in tau accumulation. This was not a compensatory phenomenon, as the functional consequence of increasing tau burden in Alzheimer's disease was a progressive weakening of the connectivity of these same nodes, reducing weighted degree and local efficiency and resulting in weaker 'small-world' properties. Conversely, in PSP, unlike in Alzheimer's disease, those nodes that accrued pathological tau were those that displayed graph metric properties associated with increased metabolic demand and a lack of trophic support rather than strong functional connectivity. Together, these findings go some way towards explaining why Alzheimer's disease affects large scale connectivity networks throughout cortex while neuropathology in PSP is concentrated in a small number of subcortical structures. Further, we demonstrate that in PSP increasing tau burden in midbrain and deep nuclei was associated with strengthened cortico-cortical functional connectivity. Disrupted cortico-subcortical and cortico-brainstem interactions meant that information transfer took less direct paths, passing through a larger number of cortical nodes, reducing closeness centrality and eigenvector centrality in PSP, while increasing weighted degree, clustering, betweenness centrality and local efficiency. Our results have wide-ranging implications, from the validation of models of tau trafficking in humans to understanding the relationship between regional tau burden and brain functional reorganization.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAniline CompoundsBrain MappingCarbolinesConnectomeFemaleHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysOxygenPositron-Emission Tomography2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleAniline CompoundsCarbolinesOxygentau ProteinsThiazolesAlzheimer’s diseasefunctional connectivitygraph theoryprogressive supranuclear palsytau

Identifiers

PMID29293892
PMCPMC5837359
OpenAlexW2766289228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.